Skip to content

Prevalence of Frailty Among People Aged 75 and Over Living at Home

Prevalence of Frailty Among People Aged 75 and Over Living at Home

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05163457
Acronym
FRAIL-DOM
Enrollment
100
Registered
2021-12-20
Start date
2022-01-06
Completion date
2022-02-22
Last updated
2022-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Frailty

Keywords

Frailty - SEGAm - living at home

Brief summary

The aging of population lead to study ways to prevent dependence. Frailty is a precursor to dependence which can be reversible. In the literature, estimate of prevalence of frailty is highly variable depending on the frailty definition, the population studied and the screan tool used. In fact, many scales to measure frailty have emerged without gold standard. The SEGAm showed its usefulness in aged patients living at home.

Detailed description

The aim of the study is to describe prevalence of frailty in patients aged of 75 and more living at home.

Interventions

OTHERData collection

frailty evaluation

Sponsors

Université de Reims Champagne-Ardenne
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
75 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* male or female * aged of 75 and more * living at home * agreeing to participate in the study

Exclusion criteria

\- none

Design outcomes

Primary

MeasureTime frameDescription
FrailtyDay 0Frailty evaluated using SEGA modified scale (SEGAm). SEGAm includes 13 items (coded from 0 to 2) to obtain a global score out of 26 points. Patients with a score less than or equal to 8 are considered not fragile. Patients with a score between 8 and 11 are considered fragile. Patients with a score greater than or equal to 11 are considered very fragile.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026